Risk and Benefits of High Dose Treatment with Busulphan-Melphalan in High Risk Neuroblastoma: The European Experience

Track: Pediatric BMT Program
Thursday, February 12, 2015, 4:45 PM-5:30 PM
Grand Hall AB (Manchester Grand Hyatt)
Ruth Ladenstein, MD , BMT Unit, St. Anna Children's Hospital, Vienna, Austria
Audio File Recorded Presentation
Disclosures:
Nothing To Disclose
See more of: (PEDS) International: Neuroblastoma & VOD
See more of: Pediatric BMT Program
<< Previous Presentation | Next Presentation